logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > Clorsulon CAS 60200-06-8

Clorsulon CAS 60200-06-8

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 60200-06-8

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
60200-06-8
Appearance::
White To Off-white Crystalline Powder
Molecular Formula::
C8H8Cl3N3O4S2
Molecular Weight::
380.65600
EINECS NO::
380.65600
MDL NO::
MFCD00072006
CAS NO::
60200-06-8
Appearance::
White To Off-white Crystalline Powder
Molecular Formula::
C8H8Cl3N3O4S2
Molecular Weight::
380.65600
EINECS NO::
380.65600
MDL NO::
MFCD00072006
Clorsulon CAS 60200-06-8

Product Description:

Product Name: Clorsulon CAS NO: 60200-06-8

 

 

Synonyms:

4-amino-6-(trichloroethenyl)-3-benzenedisulfonamide;

curatrem;

keluosuolong;

 

 

Chemical & Physical Properties:

Appearance: White to off-white crystalline powder

Assay :≥99.0%

Density: 1.8 g/cm3

Boiling Point: 651.7℃ at 760 mmHg

Melting Point: 200 – 207℃

Flash Point: 348℃

Refractive Index: 1.664

Storage Condition: 0-6℃

 

 

Safety Information:

RTECS: CZ9090000

HS Code: 2935009090

Safety Statements: S24/25

WGK Germany: 2

 

 

Clorsulon is used in the treatment of Fasciola hepatica infections in calves and sheep.Target: AntiparasiticClorsulon is a competitive inhibitor of both 3-phosphoglycorate and ATP and had a Ki of 0.29 mM, inhibits glucose utilization and acetate and propionate formation by mature Fasciola hepatica in vitro. Clorsulon (a single dose of 15 mg/kg) is effective in removing over 90% of immature Fasciola hepatica from sheep (6 weeks after infection) and calves (8 weeks after infection). A 2.5 mg/kg dose removed over 90% of mature (16 weeks old) liver fluke from sheep. Clorsulon causes severe disruption to the tegument and gut of Fasciola hepatica after in vivo incubation.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.